Our laboratory has focused on DCLK1, a calmodulin-like kinase not only because it was originally identified to mark quiescent stem cells in the normal intestine, but also that it is a marker for colon cancer stem cells [46]. This evidence concerns the gene DCLK1 and malignant colon neoplasm.